MedCity News
JANUARY 21, 2024
Adoption of value-based care has been slower in rural communities. With many rural providers struggling to even stay afloat, it can be difficult to switch to value-based care, according to one healthcare executive.
pharmaphorum
JANUARY 21, 2024
Bristol-Myers Squibb’s Opdivo-Yervoy regimen improves PFS as first-line therapy for patients with MSI-H/dMMR colorectal cancer in CheckMate-8HW trial
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JANUARY 21, 2024
Here are the key trends that will need to be top of mind for provider organizations that are transitioning to VBC, or looking to improve their performance under value-based contracts.
pharmaphorum
JANUARY 21, 2024
A vote by the HELP committee in the US on 31st January could result in the CEOs of Johnson & Johnson and Merck being forced to testify on drug pricing
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
JANUARY 21, 2024
During a recent webinar, industry leaders agreed that virtual-first health plans have significant potential to cut costs and improve members’ experiences — if executed well. They also noted that employers are more willing than ever to adopt these types of plans.
Pharmaceutical Technology
JANUARY 21, 2024
CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Sales Pilot Medical Sales Performance
JANUARY 21, 2024
Recently, I came across this post from my LinkedIn connection, Patrick Jamnik, President of Episurf Medical. It had me laughing out loud, first, because it’s clever and well-written, and second because it’s accurate. As someone who has presented at countless national sales meetings for medtech companies, Patrick’s humorous categorization of the different types of “guys” is spot on!
MedCity News
JANUARY 21, 2024
The FDA said Amgen’s Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug’s black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines.
Expert insights. Personalized for you.
121 
Let's personalize your content